AKT1 and endometrial cancer: The previously paper reported that reduced m6A mRNA methylation as an oncogenic mechanism in endometrial cancer and identify m6A methylation as a regulator of AKT signaling 17, we predicted that the m6A modification associated enzymes maybe the key regulators of the endometrial cancer.